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Alveolar macrophages play a key role in defense of the host against pulmonary 
infection (1-6). Their clinical importance is emphasized by the high incidence of 
life-threatening pneumonia (7, 8) in patients with abnormal macrophage function 
(6)  or  impaired  ceU-mediated immunity (6-9).  However,  the  mechanisms by 
which alveolar macrophages kill microorganisms are poorly understood. 
We recently examined the mechanism by which human alveolar macrophages 
kill  the intracellular parasite,  Toxoplasma  gondii  (10).  We chose this organism 
because it causes pneumonia in immunosuppressed patients (11-14) but not in 
healthy individuals (11), and because macrophages play an important part in the 
host's resistance to this organism (5,  15-17).  Our studies showed that killing of 
T. gondii by human alveolar macrophages occurred without involvement of toxic 
metabolites  of oxygen (Catterall, J.  R.,  and J.  S.  Remington,  manuscript  in 
preparation).  This  suggested  that  previous  studies  of intracellular  killing  by 
normal macrophages might have limitations as models for the human alveolar 
macrophage, since most of them (18-20, and reviewed in 21), including all those 
that employed T. gondii (18-23), have emphasized the overriding importance of 
oxidative killing mechanisms. Nonoxidative antimicrobial activity has been shown 
in subcellular macrophage fragments (21, 24) and in oxidatively deficient cells 
(19, 21-23,  25), but in none of the previously described models using normal 
intact macrophages has the killing  of intracellular parasites  been  reported as 
nonoxidative. 
To facilitate the study of nonoxidative killing by alveolar macrophages, we 
have sought a  laboratory animal model relevant to the human alveolar macro- 
phage. Since rats more closely resemble human subjects in their resistance to T. 
gondii  than  many other  animals  (26,  27),  we  have  examined the  interaction 
between T. gondii and rat alveolar macrophages in vitro. The studies reported 
here indicate that rat alveolar macrophages, like those from human subjects, also 
kill T. gondii, and by nonoxidative mechanisms. They suggest that nonoxidative 
antimicrobial mechanisms may be important in alveolar macrophages, and they 
provide a convenient model for the study of such mechanisms. 
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Materials and  Methods 
Animals.  Lewis rats,  6-8  wk  old  and  weighing  180-220  g  each  (Harlan  Sprague 
Dawley Inc., Indianapolis, IN) were used for most experiments. Sprague-Dawley rats of 
similar age and weight (Simonsen  Laboratories, Gilroy, CA) were used as noted.  Mice 
were outbred Swiss-Webster females, 6-8 wk old, and weighed 20-22 g each (Simonsen 
Laboratories). 
Macrophages.  Animals were killed by asphyxiation with carbon dioxide, and resident 
peritoneal macrophages harvested by lavaging the peritoneal cavity once with calcium- 
and magnesium-free PBS (Gibco Laboratories, Grand Island, NY) containing EDTA 0.1 
g/100 ml (PBS-EDTA). We obtained resident alveolar macrophages by repeatedly tavag- 
ing the lung in situ (28) with PBS-EDTA until  100 ml (rat) or  10 ml (mouse) of lavage 
fluid had been collected from each animal. For most experiments, cells from 2-6 rats, or 
10-12 mice, were pooled. 
The lavage fluid was centrifuged at 225 g for 10  rain at 4°C, and the pellet of cells 
washed with PBS, recentrifuged, and resuspended in serum-free Iscove's modified Dul- 
becco's medium (IMDM'; Gibco Laboratories) containing gentamicin 40 mg]liter (here- 
after  termed  medium).  In  all  experiments,  with  both  resident  alveolar  and  resident 
peritoneal cells,  >92% of the leukocytes in these suspensions were mononuclear cells on 
Diff-Quik- (American Scientific Products, McGraw Park, IL) stained cytocentrifuge prep- 
arations. The concentration ofmononuclear cells was adjusted to 2 x  106/ml with medium, 
and a  300-~tl aliquot of this suspension was inoculated into individual wells of an eight- 
chamber tissue culture slide (Lab-Tek Products, Naperville, IL). The cells were incubated 
for 2 h at 37°C in air containing 5% CO~ and washed twice with PBS.  The monolayers 
were used immediately or after 18 h of further incubation in medium. As mouse alveolar 
cells were less plentiful than rat cells, they were inoculated into each culture chamber in 
a 50-/A dot placed at the center of the chamber (5); we were careful not to dislodge this 
dot of the cell suspension as the slide was placed into the incubator. >95% of the cells in 
the monolayers were mononuclear phagocytes, as assessed by their ability to ingest neutral 
red. 
Organisms.  Tachyzoites of the RH strain of T. gondii were harvested and processed by 
methods described previously (18),  suspended  in  medium at concentrations of 2-12  x 
10~/ml, and immediately added to the macrophage monolayers. The concentration of the 
Toxoplasma suspension used in most experiments was 6  x  10~/ml, since  300  ttl of this 
suspension was usually sufficient to infect 20-55% of macrophages. Yeast-phase Candida 
albicans, previously killed by boiling for 30 rain and stored at 4°C in PBS, were suspended 
in  medium also at a  concentration  of 2-12  x  106/ml.  Killed  Corynebacterium parvum, 
7 mg/ml, (Wellcome Research Laboratories, Beckenham, England) was used undiluted. 
Special Reagents.  Reagents were obtained from Sigma Chemical Co., St.  Louis, MO, 
and dissolved in medium immediately before use, unless indicated otherwise.  PMA was 
dissolved in  DMSO at a concentration of 0.3  mg/ml, separated into 50-ttl  aliquots, and 
stored at -70°C (29, 30). 
Scavengers of oxygen metabolites (19, 23, 31) were used at the concentrations shown. 
They included catalase from bovine liver recrystallized twice (2.5  and  1.3  mg/ml) as a 
scavenger of hydrogen peroxide; superoxide dismutase, type III, 3,000  U/mg (2.5 and 
1.3 mg/ml) as a scavenger of superoxide anion; and histidine (10 raM) and diazabicyclooc- 
tane (DABCO, 1 raM) as scavengers of singlet oxygen radicals. The scavengers of hydroxyl 
radicals used were mannitol (50  mM), benzoic acid (10 raM),  DMSO (150  raM), tetra- 
methylurea (25 raM), thiourea (25 raM), methanol (315 raM), and ethanol (80 raM). 
Injection  of Macrophage Monolayers and Assessment of Intracellular  Killing.  A  300-ttl 
aliquot of the Toxoplasma suspension was added to each monolayer, the organisms were 
incubated  with  the  cells  for  1  h,  and  then  extracellular  organisms were  removed  by 
washing the monolayers five times with PBS.  Immediately thereafter (0 h), and at varying 
intervals later, duplicate monolayers were fixed in cold (4°C) aminoacridine fixative (5), 
i Abbreviations used in this paper:  CGD,  chronic granulomatous disease; DABCO, diazabicyclooc- 
tane; IMDM, Iscove's modified Dulbecco's medium; medium, serum-free IMDM containing genta- 
micin 40 rag/liter;  NBT, nitroblue tetrazolium dye. CATTERALL  ET  AL.  1115 
stained with Diff-Quik, and examined for morphologically intact intracellular Toxoplasma 
(32). A rosette was defined as eight or more Toxoplasma in a single vacuole. The number 
of infected  macrophages,  the  number of Toxoplasma per  100  macrophages, and  the 
number of macrophages that contained rosettes were determined by counting at least 200 
cells in  each  monolayer. All  counts  were performed on  duplicate  monolayers and the 
mean values calculated. 
Toxoplasmacidal activity was also assessed by acridine orange fluorescence microscopy 
(19, 23, 33, 34).  Macrophage monolayers were incubated with acridine orange (5 #g/mi 
in HBSS) for 20 min at 37°C, washed, and incubated in dye-free medium for 1 h. Viable 
or formalin-killed Toxoplasma were then  added to the monolayers. After 30 min, the 
slides were washed, then examined either immediately by epifluorescence microscopy or 
after incubation in medium for varying intervals. Toxoplasma were scored as dead if they 
showed uniform yellow-green, orange, or red staining of their cytoplasm. However, if 
they showed only punctate  orange lysosomal staining,  faint dull  green staining,  or no 
discernable  cytoplasmic staining,  they  were  not  scored as dead.  The  total  number of 
intracellular Toxoplasma (both morphologically intact and partially digested) was deter- 
mined from slides run in parallel that were fixed and stained with Diff-Quik stain. Control 
experiments were performed with Toxoplasma in suspension; viable Toxoplasma stained 
with acridine orange were killed by adding either hydrochloric acid (to lower the pH to 
4.5) or formalin (to give a  final formaldehyde concentration of 4%) to the suspension, 
and  examined  by epifluorescence  microscopy after  varying intervals of incubation  at 
37°C. 
Intracellular Reduction of  Nitroblue Tetrazolium (NBT) Dye.  NBT dye, at a concentration 
of 0.25  mg/ml  medium,  was  incubated  for  1  h  with  macrophage  monolayers in  the 
presence of live tachyzoites of T. gondii or heat-killed Candida,  in eight-chamber tissue 
culture  slides (Lab-Tek Products)  (18).  The slides were then  rinsed  in  saline,  fixed in 
methanol, and counterstained with 0.2% safranin. The percentage of macrophages that 
contained formazan granules within phagocytic vacuoles was determined microscopically 
by counting 100-200 cells that contained organisms. Cells were scored as positive only if 
they contained organisms surrounded by deep blue staining. Macrophages that contained 
only diffuse fine deposits of formazan were present in similar numbers in challenged and 
unchallenged monolayers; they were therefore scored as negative. 
Release  of Superoxide  From  Rat  Alveolar  Macrophages.  The  amount  of superoxide 
released from monolayers of rat alveolar macrophages in response to  PMA (200  nM), 
heat-killed Candida (at organism/macrophage ratios of 3:1 and 6:1), or live tachyzoites of 
T. gondii (at the same organism/macrophage ratios) was measured by the method of Pick 
and  Mizel  (35),  which  uses reduction  of ferricytochrome c.  Macrophages (3  ×  105 per 
well) were incubated in quadruplicate in 96-well flat-bottomed tissue culture plates (Costar, 
Cambridge, MA), and measurements of absorbance at 550 nm made in a  micro-ELISA 
reader (Dynatech Laboratories Inc., Alexandria,  VA).  The amount of superoxide pro- 
duced was calculated from the formula (35): nanomoles of superoxide per well = (absorb- 
ance at 550 nm x  100)/6.3. 
Intracellular Killing  of T. gondii After Pretreatment  of Rat Alveolar Macrophages  With 
PMA.  Rat alveolar macrophages were incubated with medium containing 200 ng/ml of 
PMA and  0.07%  of DMSO  (vol/vol) for 90  min at 37°C  in  5%  CO2  to exhaust their 
respiratory burst (29).  The monolayers were washed twice, reincubated in medium alone 
for 2 h (29), and then infected with tachyzoites of T. gondii and assessed for toxoplasmacidai 
activity. The impaired capacity of the macrophages to generate a respiratory burst after 
pretreatment with PMA was confirmed by assessing their reduction of NBT dye in the 
presence of heat-killed Candida. In control experiments, the macrophages were pretreated 
with 0.07% DMSO alone. 
Effects of Scavengers of Oxygen Metabolites on the Toxoplasmacidal  Activity of Rat Alveolar 
Macrophages.  Rat  alveolar  macrophages  were  incubated  with  scavengers  of oxygen 
metabolites dissolved  in  medium  (at  the  concentrations  stated  under  special  reagents 
above), or with medium alone, for 3 h before infection with 7". gondii, during the period 
of infection, and for 18 h thereafter (19).  Slides were fixed and stained at 0, 6, and 18 h, 1116  OXYGEN-INDEPENDENT KILLING  BY  ALVEOLAR MACROPHAGES 
and examined to determine the number of infected cells and the number of morpholog- 
ically intact Toxoplasma per 100 cells. Control experiments were performed with murine 
peritoneal macrophages that had been activated to kill T. gondii by intraperitoneal injection 
of the mice with  1.4 mg of killed  C. parvum 21-30 d earlier (5, 36). 
Effect of Permeant  Weak Bases on  the  Toxoplasmacidal Activity of Rat Alveolar  Macro- 
phages.  To determine  whether acidification of the phagosome by lysosomes  plays  an 
important part in the toxoplasmacidal activity of rat alveolar macrophages, monolayers of 
these cells were incubated with weak bases that have been shown to raise the intralysosomal 
pH of phagocytes (37,  38).  The monolayers were incubated with 300 tti of ammonium 
chloride (10 mM),  methylamine (10 mM),  or medium alone for 15 min (38),  then 33 #1 
of a suspension of Toxoplasma containing 6 x  107 organisms/ml was added to each well. 
After  1 h  of further incubation in the presence of the base,  extracellular Toxoplasma 
were removed by washing, and the slides were fixed, stained, and examined microscopic- 
ally, either immediately or after varying periods of incubation with the same weak base 
or medium alone.  Parallel  experiments  were performed with  mouse peritoneal macro- 
phages as a control. 
To confirm that the intralysosomal pH of the macrophages had actually been raised, 
we determined the ability  of the macrophages to concentrate acridine orange into their 
lysosomes, a process that is dependent on low intralysosomal pH (34, 39). This was done 
in parallel  with the studies with weak bases described above. Monolayers from the same 
suspensions  of macrophages were incubated with  10 mM ammonium chloride,  10 mM 
methylamine, or medium alone for 15 min, 6 h, or 18 h. At the end of each of these time 
periods, a small volume of acridine orange was added to the incubation solution to give a 
final acridine orange concentration of 5 #g/ml. After 20 min of  incubation, the monolayers 
were washed five times with weak base or control medium to remove extracellular acridine 
orange. They were reincubated for 1 h with the same weak base or control medium but 
without  acridine  orange.  They  were  then  washed  and  examined  by  epifluorescence 
microscopy to determine the percentage of cells in each monolayer that had lysosomes 
that were stained bright orange. 
Viability of Toxoplasma Attached to the Surface of Rat Alveolar Macrophages.  To examine 
whether Toxoplasma are killed  at the surface of alveolar macrophages, we determined 
the viability  of Toxoplasma that were attached to the cells. Toxoplasma incubated with 
acridine orange (10 ttg/ml) for 30 rain  were added to monolayers of rat alveolar macro- 
phages that had also been incubated with acridine orange (10/Lg/ml). It was necessary to 
use  10  #g/ml  of acridine  orange  and  to  prelabel  the  macrophages,  as  well as  the 
Toxoplasma, because macrophages and Toxoplasma compete for the dye, and when these 
procedures were not followed there was a tendency for acridine orange in the Toxoplasma 
suspension to be redistributed  to the macrophages, thus making it difficult to visualize 
lysosomal  staining in  Toxoplasma. The Toxoplasma and  macrophages were  incubated 
together  for  20  rain,  extracellular  organisms  were  gently  washed  off once,  and  the 
Toxoplasma attached to the macrophages were examined for viability by epifluorescence 
microscopy. 
Since  Toxoplasma (both live and dead) are internalized rapidly by macrophages, the 
experiment was repeated with sodium fluoride to block phagocytosis of the organisms. 
Sodium fluoride has previously been shown to prevent entry of latex beads (40) and yeast 
cells (41)  into macrophages, although it may have a  wide range of effects of cells (42). 
Monolayers of rat  alveolar  macrophages  were  incubated  for  1  h  with  medium  that 
contained acridine orange (10 pg/ml) and 5 m M sodium fluoride, preliminary experiments 
having shown this to be the lowest concentration of fluoride that would prevent ingestion 
of Toxoplasma by these cells. The incubation fluid was then aspirated and replaced by a 
suspension of T. gondii in HBSS that contained  10 t~g/ml of acridine orange and 5 mM 
sodium fluoride. After 2 h, extracellular Toxoplasma were gently washed off once, and 
the Toxoplasma attached to the macrophages were examined for viability by epifluores- 
cence microscopy (19, 23, 33, 34). In control experiments, the suspension of Toxoplasma 
was incubated with sodium fluoride and acridine orange, but without rat alveolar macro- CATTERALL  ET  AL.  1117 
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FIGURE  1.  Fate of T. gondii  in macrophages from  rats and mice.  Results are  the mean _+ 
SEM  of  four  experiments  performed  in  duplicate,  except  for  those  with  mouse  alveolar 
macrophages, wbich are the mean _+ SEM of two experiments performed in duplicate. In all 
experiments with rat macrophages, the viability of the inoculum of 7". gondii tachyzoites was 
confirmed by docmnenting their ability to multiply in resident murine peritoneal macrophages. 
phages.  Also, acridine orange-stained Toxoplasma were incubated with  monolayers of 
rat alveolar macrophages in the absence of sodium fluoride. 
Values are expressed as means  __. SEM. Differences  between values were determined 
by Student's t test. 
Results 
Fate  of  T.  gondii  in  alveolar  and  Peritoneal  Macrophages  From  Rats  and 
Mice.  Resident  rat  alveolar  macrophages  killed  T. gondii  in  vitro.  18  h  after 
entering these cells, most of the Toxoplasma had disappeared and almost all of 
the remaining  organisms had lost their morphological integrity; none had mul- 
tiplied. In contrast, organisms from the same Toxoplasma suspensions multiplied 
readily  inside  resident  murine  alveolar  macrophages  (Fig.  1).  This  marked 
difference between rats and mice in the resistance of their alveolar macrophages 
to  T.  gondii  was  also  noted  in  experiments  run  in  parallel  with  peritoneal 
macrophages from the same animals (Fig.  1). Because our main interest was in 
pulmonary defenses, all subsequent experiments were performed with alveolar 
macrophages. 
In these and all subsequent experiments with rats,  Lewis strain animals were 
used. In a separate series of experiments,  alveolar and peritoneal macrophages 
from Sprague-Dawley rats were found to have an ability to kill  T. gondii similar 
to that observed with the same cells from Lewis rats (data not shown). 
Toxoplasmacidal  Activity  of Rat  Alveolar  Macrophages.  The  toxoplasmacidal 
activity of rat alveolar macrophages was both rapid (Fig. 2) and efficient (Table 
I). 
To determine  how quickly rat  alveolar  macrophages  kill  T. gondii,  infected 
monolayers were examined at varying times after infection. Even when morpho- 
logical criteria were used to assess destruction of the organism in fixed prepara- 1118  OXYGEN-INDEPENDENT  KILLING  BY  ALVEOLAR  MACROPHAGES 
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FIGURE 2.  Fate of T. gondii in rat alveolar macrophages, mouse peritoneal macrophages, and 
medium containing formalin or acid, as indicated by acridine orange staining of the organism 
(see text for details).  In A and B,  macrophages whose  lysosomes had been prelabeled with 
acridine orange were incubated for 30 rain (m) with viable (O, 0) or formalin-killed (I-3, D) 7". 
gondii, washed, and examined microscopically, either immediately or after varying periods of 
further incubation. The total number of intracellular organisms was determined in Diff-Quik- 
stained fixed preparations, and the number of dead organisms was determined by acridine 
orange fluorescence microscopy. In C, viable Toxoplasma stained with acridine orange were 
suspended in medium, and acid (<>) or formalin (A) added at the time marked by the arrow. 
The open symbols represent Toxoplasma suspended in medium, the closed symbols represent 
intracellular organisms. The results are the mean of three separate experiments. 
TABLE  I 
Fate of T. gondii in Rat Alveolar Macrophages and in Activated Mouse 
Peritoneal Macrophages 
Percent mac-  Toxoplasma 
Macrophages used:  rophages in-  per 100 macro- 
fected*  phages * 
Rat alveolar macrophages: 
0h  71--  13  208-56 
18h  2-+1  2+1 
Activated mouse peritoneal macrophages:* 
0 h  53 -+ 7  139 -+ 23 
18h  8-+3  30+15 
* The results are the means 4-_ SEM of three experiments. 
Peritoneal macrophages from mice infected with C56 strain of T. gondii 6-8 
wk earlier (see text). 
tions, 76% (range 70-86%  in three experiments) of the parasites that appeared 
morphologically intact at the end of the hour-long infection period had become 
shrunken  remnants,  without  the  usual  clear  distinction  between  nucleus  and 
cytoplasm, 2 h later. However, studies with acridine orange suggested that most 
of the organisms were killed during their first hour of exposure to the monolayers 
(Fig. 2). 
Rat  alveolar  macrophages  also  showed  a  remarkable  ability  to  kill  large 
numbers  of Toxoplasma.  In  three  experiments  (Table  I),  rat  alveolar  macro- 
phages were incubated with two to three times the usual inoculum  of T. gondii CATTERALL  ET  AL.  1119 
to give high initial infection rates.  18 h later, only 2% of the original number of 
intracellular Toxoplasma appeared morphologically intact, and none had multi- 
plied  (Table  I).  We  compared  the  toxoplasmacidal  capacity  of rat  alveolar 
macrophages with that of mouse peritoneal macrophages that had been activated 
to kill T. gondii by intraperitoneal injection of 105 tachyzoites of the tow-virulent 
C-56 strain of T. gondii  6-8  wk earlier.  Macrophages were harvested at these 
times because in previous studies in our laboratory they were highly activated to 
kill or inhibit T. gondii (5).  These activated peritoneal macrophages killed most 
of the  intraceilular Toxoplasma  (Table  I),  but  in  two  of three experiments, 
replication of the organism did occur in  a  few cells (Table  I), suggesting that 
these populations of activated macrophages were more heterogeneous in their 
toxoplasmacidal  activity  than  the  populations  of resident rat  alveolar  macro- 
phages. 
Release of Superoxide by  Rat  Alveolar  Macrophages.  When  T.  gondii  were 
incubated with rat alveolar macrophages in the presence of NBT, <5%  of the 
macrophages that contained intracellular Toxoplasma showed reduction of NBT, 
even though organisms from the same suspensions of Toxoplasma were killed 
by the macrophages. When monolayers of the same macrophages were incubated 
with heat-killed Candida, however, NBT reduction was seen in the majority (73- 
97% in five experiments) of rat alveolar macrophages that contained Candida. 
The foregoing results indicated that rat alveolar macrophages killed intracel- 
lular T. gondii without their respiratory burst being triggered. To confirm these 
findings,  activation  of the  respiratory  burst  was  assessed  by  quantitating  the 
liberation of superoxide from rat alveolar macrophages (Fig.  3).  The  macro- 
phages readily released superoxide in response to PMA or heat-killed Candida 
(Fig. 3), but when incubated with Toxoplasma they released no more superoxide 
than resting cells (peak superoxide level per well with resting cells, 0.37 +  0.21 
nmol; with cells exposed to T. gondii, 0.51  +  0.35 nmol, p >  0.2). In concurrent 
experiments, however, alveolar macrophages from the same animals ingested 
and killed organisms from the same suspensions of Toxoplasma (data not shown). 
Fate of IntraceUular  T.  gondii  in  Rat  Alveolar  Macrophages Pretreated With 
PMA.  PMA, a  phorbol diester, triggers and exhausts the respiratory burst of 
phagocytes  (29).  Pretreatment  of rat  alveolar  macrophages  with  PMA  (200 
ng/ml) for  90  min  did  not  significantly affect the rat  alveolar  macrophages' 
ability to kill  intracellular Toxoplasma, even though the treated macrophages 
showed a greatly impaired capacity to reduce NBT in the presence of heat-killed 
Candida  (Fig.  4).  Because of a  recent report  (30)  that  PMA  will  trigger  the 
respiratory burst  of alveolar  macrophages most  effectively if the  monolayers 
have been pre-exposed to serum for 24-48  h,  this experiment with PMA was 
repeated  using  ~'at alveolar  macrophages  that  had  been  cultured  in  IMDM 
containing 10% FCS for 48 h. The results obtained were similar to those without 
serum pretreatment and are included in Fig. 4. 
Effect of Scavengers of Oxygen Metabolites.  Previous experiments with activated 
murine peritoneal macrophages have shown that scavengers of oxygen metabo- 
lites can impair the ability of these cells to kill  intracellular T. gondii, provided 
that the scavengers are incubated with the cells for at least 3 h before infection 
as well as during infection and the subsequent  18  h  (19).  However, when we ] 120  OXYGEN-INDEPENDENT  KILLING  BY  ALVEOLAR  MACROPHAGES 
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FIGURE 3.  Production of superoxide by rat alveolar macrophages. Macrophage monolayers 
were made by seeding 3 x  105 mononuclear cells in 96-well flat-bottomed tissue culture plates. 
The  monolayers  were  incubated  with  PMA  (200  nM,  O),  heat-killed  Candida  (at  orga- 
nism/macrophage  ratios  of  3:1,  #,  and  6:1,  O,  live  tachyzoites  of  T.  gondii  (at  orga- 
nism/macropbage ratios of 3:1, l, and 6:1, ~  or medium alone (0). The amount of superoxide 
in each well was calculated from measurements of absorbance at 550 nm at the times indicated. 
The results are the means +  SEM of quadruplicate monolayers from one experiment. The 
figure is representative of two similar experiments. 
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FIGURE 4.  Fate of T. gondii in rat alveolar macrophages pretreated with PMA. Monolayers 
of rat alveolar macrophages were pretreated with PMA (200 ng]ml medium containing 0.07% 
DMSO; O, solid bar) or with control medium (O, open bar) containing 0.07% DMSO alone. 
The ability of the cells to kill 7". gondii (A), or their reduction of NBT dye during incubation 
with heat-killed Candida (B), were then assessed in parallel (see text for details). Results are 
the means +  SEM of four experiments run in duplicate, except for those at 40 h, which are 
the mean of duplicate results from one experiment. MS, macrophages. CATTERALL  ET  AL.  1121 
TABLE II 
Effect of Scavengers of Oxygen Metabolites on the Toxoplasmacidal 
Activity of Rat Alveolar Macrophages 
Medium supplemented with: 
Number  Toxoplasma per 
of ex-  100 macrophages 
peri- 
ments  0 h  18 h 
Medium only*  4  40 ±  6  ~  5 ±  2 
Superoxide dismutase (2.5 mg/ml)  3  42 ±  5  3 ±  1 
Catalase (2.5 mg]ml)  4  43 ±  7  2 ±  1 
Histidine (10 raM)  4  46 +  9  3 ±  2 
DABCO (1  mM)  3  48 ±  5  3 +  1 
Mannitol (50 mM)  4  40 ±  3  3 ±  1 
Benzoate (25 raM)  2  50 +  4  5 _  2 
Tetramethylurea (25  raM)  2  48 ±  3  6 +__ 5 
Thiourea (25 raM)  2  41  ±  5  2 ±  1 
DMSO (150 raM)  2  54 +  9  4 "4- 2 
Ethanol (80 raM)  2  56 --. 3  9 ±  2 
Methanol (315 raM)  2  58 +  11  8 +  3 
* Macrophage  monolayers  were  incubated  in  duplicate  with  medium 
alone, or with medium containing scavengers, for 3 h before infection, 
during infection, and for 18 h thereafter. 
* The results are the means _  SEM of two to four experiments. 
incubated our rat alveolar macrophages with scavengers of oxygen metabolites 
under the same conditions, their toxoplasmacidal activity was not affected by any 
of the 11 scavengers tested (Table II). 
As a positive control for these studies, parallel experiments were performed 
with mouse peritoneal macrophages that had been activated to kill Toxoplasma 
by prior intraperitoneal injection of C. parvum (36).  Most of the scavengers so 
tested (Fig.  5) did inhibit or slow the toxoplasmacidal activity of the activated 
murine peritoneal macrophages under these conditions, but the effect was clear 
only at 6 h (Fig. 5). Replication of Toxoplasma was seen in only one instance (an 
experiment with histidine, data not shown), and even in this instance there was 
a rise of only 3 Toxoplasma per 100 macrophages between 6 and 18 h because 
the replication of Toxoplasma in some macrophages was balanced by the killing 
of Toxoplasma in other cells. The scavengers also consistently altered the uptake 
of Toxoplasma  by  these  activated  murine  peritoneal  macrophages  (Fig.  5), 
although this did not occur with the rat alveolar macrophages. Furthermore, the 
scavengers inhibited  killing only if the interval  between administration of C. 
parvum  and  harvest of the macrophages was >21  d.  The  scavengers had no 
obvious  effect on  the  toxoplasmacidal  activity of activated  mouse  peritoneal 
macrophages harvested <21  d  after the C. parvum  injection (data not shown), 
confirming previous observations (19) that the effects of scavengers in this (19) 
and similar (36) assays are critically dependent on the degree of activation of the 
macrophages. 
Effect of Permeant  Weak Bases.  Treatment of rat alveolar macrophages with 
weak bases  that are known to raise intralysosomal pH  had no effect on  their 
ability to kill  T. gondii (Table III). This was not due to a  direct toxic effect of 
the bases  (or  of raised  intralysosomal pH)  on  either  the  Toxoplasma  or  the 1122  OXYGEN-INDEPENDENT  KILLING  BY  ALVEOLAR  MACROPHAGES 
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FIGURE 5.  Effects of scavengers of oxygen metabolites on the Toxoplasmacidal activity of 
(A) resident rat alveolar macrophages and (B) murine peritoneal macrophages activated to kill 
T. gondii. The activated murine peritoneal macrophages were harvested 24 d  after injecting 
the mice with killed C. parvum.  Macrophage monolayers were incubated with medium alone 
or with medium containing scavengers for 3  h  before infection, during infection, and  18 h 
thereafter.  The  experiments  were  performed  in  duplicate  and  in  parallel.  The  figure  is 
representative of two similar experiments. 
TABLE  IlI 
Effect  of Permeant Weak Bases on the Toxoplasmacidal Activity of Rat 
Alveolar Macrophages 
Medium supplemented with: 
Toxoplasma per 100 macro- 
phages 
Oh  18h 
Medium only*  53 --- 6*  2 +  1 
Ammonium chloride (10 raM)  56 --+ 4  3 +_ 2 
Methylamine (10 raM)  43 4- 9  0 +  0 
* Macrophage monolayers were incubated in duplicate with medium alone 
or with medium containing a  weak base, for  15 min before infection, 
during infection, and for 18 h thereafter. 
The results are the means +  SEM of two experiments. 
macrophages, since Toxoplasma multiplied intracellularly when the experiment 
was repeated with mouse peritoneal macrophages (Fig.  6).  Moreover, as shown 
in  Fig.  6,  the  weak  bases  markedly  reduced  the  macrophages'  capacity  to 
concentrate acridine orange, confirming that the intralysosomal pH of these cells 
was elevated throughout the experiment (38). 
Viability  of  Toxoplasma  attached  to  the  Surface  of  Rat  Alveolar  Macro- 
phages.  Toxoplasma attached to the surface of macrophages were not killed, as 
judged by acridine orange staining. After gentle washing of monolayers that had 
been incubated with Toxoplasma for 20 min, only a few (<5%) of the macro- 
phages had Toxoplasma attached to their surface, but the proportion of these 
organisms that appeared dead was similar to the proportion of dead organisms 
in suspensions of Toxoplasma. 
Even  when  ingestion  of Toxoplasma  was  prevented  by  incubation  of the 
macrophages with sodium fluoride, thus allowing us to observe the organisms CATTERALL  ET  AL.  1123 
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FIGURE  6.  Effect of permeant weak bases  on  the Toxoplasmacidal  activity of rat alveolar 
macrophages, the multiplication of T. gondii  in mouse peritoneal macrophages, and the ability 
of the macrophages to concentrate  acridine orange (AO) in lysosomes. Duplicate monolayers 
of rat alveolar macrophages were incubated with 10 mM ammonium chloride (A, striped bar), 
10 mM methylamine (rl, open bar) or medium alone (O, stippled bar). The fate of T. gondii in 
the macrophages  (A), and the ability of the macrophages  to concentrate  acridine orange  in 
lysosomes (B),  were then  determined.  See  Materials  and Methods  for details.  The figure  is 
representative of two similar experiments. 
after they had been in contact with the cell surface for 2 h, we found no evidence 
that  they  were  killed  at  the  cell  surface.  In  three  experiments,  -20%  of the 
macrophages had Toxoplasma attached to their surface after gentle washing of 
the  monolayers,  but  these  organisms  were  not  killed,  as judged  by  acridine 
orange  staining.  Only  18  +  4%  of the  Toxoplasma  attached  to  macrophages 
were scored dead after 2 h of incubation, a figure similar to the number scored 
dead  (16  +  4%)  in  Toxoplasma  suspensions  incubated  with  sodium  fluoride. 
However,  when  acridine  orange-labeled  Toxoplasma  from  the  same  original 
suspension  were  incubated  with  rat  alveolar  macrophages  that  had  not  been 
treated with sodium fluoride, ingestion did take place and most (78 +  7%) of the 
intraceilular organisms appeared dead at 2 h. 
Discussion 
T. gondii rarely  causes serious illness in healthy adult human subjects,  but in 
the  immunosuppressed  individual  it  is  an  important  cause  of life-threatening 1124  OXYGEN-INDEPENDENT  KILLING  BY  ALVEOLAR  MACROPHAGES 
disseminated disease (13, 43, 44); pulmonary involvement is common in dissem- 
inated toxoplasmosis (11-14, 44) and may be a presenting feature of the infection 
(12,  14).  Experimentally, T. gondii  has proved to  be remarkably useful as an 
intracellular probe of macrophage function (15-23,  27,  29,  45,  46);  previous 
studies with this organism have contributed to our understanding of macrophage 
activation (21, 23, and reviewed in 46), macrophage antimicrobial processes (19, 
23), and microbial pathogenicity (18, 45). 
Our results indicate that resident rat alveolar macrophages kill T. gondii  in 
vitro, and that this killing occurs without significant involvement of toxic metab- 
olites of oxygen (18-20, 23). These findings have a number of implications: they 
suggest that rat alveolar macrophages possess a  powerful, nonoxidative antimi- 
crobial mechanism that is not present in resident murine alveolar and peritoneal 
macropbages (20, 21) or in normal human monocyte-derived macrophages (18, 
20); they suggest that the toxoplasmacidal activity of rat alveolar macrophages 
may be a  useful model for the study of nonoxidative killing by alveolar macro- 
phages (21);  and they help to  explain  the remarkable resistance of rats  to  T. 
gondii (26, 27). 
When Toxoplasma enter human monocyte-derived macrophages or resident 
murine peritoneal macrophages, they do so without triggering the respiratory 
burst of these cells (18,  23) and are thus able to survive and replicate. In our 
experiments with resident rat alveolar macrophages, T. gondii showed the same 
ability to avoid triggering the respiratory burst; nevertheless, the organisms were 
killed. This strongly suggests that rat alveolar macrophages possess a nonoxida- 
tive antimicrobial mechanism that is either not present in normal human mono- 
cyte-derived macrophages (18, 20) or murine peritoneal macrophages (5, 18,  19, 
23), or is far less active in these cells (20).  Such a  mechanism could clearly be 
important for killing other organisms that can avoid or overcome the respiratory 
burst of macrophages (21); it might also enable the cell to kill some organisms 
during severely hypoxic conditions (47),  such as exist in consolidated areas of 
lung during pulmonary infections. The exact significance of this nonoxidative 
toxoplasmacidal mechanism in the overall antimicrobial activity of the macro- 
phage remains to be established, but the fact that it can kill large numbers of T. 
gondii  suggests that it might play a significant role in the antimicrobial defenses 
of the rat alveolar macrophage. 
The toxoplasmacidai activity of the rat alveolar macrophage appears to be a 
convenient model for the study of nonoxidative killing by alveolar macrophages. 
Our recent observation that human alveolar macrophages also kill T. gondii  by 
nonoxidative processes is of particular interest (Catterall, J. R., and J. S. Reming- 
ton,  manuscript  in  preparation).  Indeed,  the model  may be  of direct clinical 
relevance to the increasing numbers of severely immunosuppressed patients, for 
there  is  evidence  that  bone  marrow  transplant  recipients  and  patients  with 
acquired  immune deficiency syndrome,  many of whom  die  of opportunistic 
pulmonary infection (7, 8), possess alveolar macrophages that are unable to kill 
T. gondii  (10, 48). Unlike healthy individuals, these patients have impaired cell- 
mediated immunity and probably cannot activate macrophages in vivo (6, 49). 
However,  further studies are needed to  determine whether the nonoxidative 
antimicrobial activity of human alveolar macrophages is due to  the same bio- CATTERALL  ET  AL.  1125 
chemical  mechanism as  that  in  rat  alveolar  macrophages,  and  whether  the 
alveolar macrophages of these and other immunosuppressed patient populations 
also show deficiencies in their oxygen-dependent antimicrobial activity. 
Previous studies in  mouse and hamster models have suggested that  macro- 
phages are important for the host's resistance to T. gondii (5,  15-17,  45,  and 
reviewed in 46). Our finding that rat alveolar macrophages readily kill T. gondii 
is consistent with that view, since rats are highly resistant to the parasite (26, 27). 
Alveolar  macrophages  in  particular  are  almost  certainly  important  for  this 
defense, since pulmonary toxoplasmosis is well recognized in a variety of animals 
(50), as well as in immunosuppressed patients (7,  11-14, 44). Our results differ 
from those of Chinchilla et al. (51), who found that T. gondii were killed by rat 
peritoneal macrophages but not by rat alveolar macrophages.  However, their 
monolayers probably contained a mixture of cell types, for they included tissue 
from ground lung, and the proportion of cells that were macrophages was not 
defined. The presence of nonphagocytic cells in a macrophage monolayer could 
alter the results,  since most nonphagocytes permit  intracellular replication  of 
intraceilular Toxoplasma  (52).  In  our experiments, >95%  of the cells in  the 
monolayers were macrophages. 
Murray and colleagues (19),  using scavengers of oxygen metabolites, showed 
the  importance  of oxidative  mechanisms  in  the  toxoplasmacidal  activity  of 
activated murine peritoneal  macrophages.  Sibley et al.  recently made similar 
observations (23), and their results with activated murine peritoneal macrophages 
closely resemble our own (Fig. 6). In contrast, the same (and additional) scaven- 
gers failed to inhibit the toxoplasmacidal activity of our rat alveolar macrophages. 
These findings alone do not exclude oxidative mechanisms, however, as illus- 
trated by our control experiments with activated mouse peritoneal macrophages; 
the scavengers inhibited the anti-Toxoplasma activity of these cells only when 
their  degree  of activation  was  decreasing  (36).  A  similar  phenomenon  has 
previously been observed with activated murine peritoneal macrophages (19, 36) 
and it has been suggested (19) that the most active cells might be producing 
more oxygen metabolites than the scavengers could overcome. If this explanation 
is correct, it  would be  impossible to  exclude oxidative killing mechanisms by 
using  scavengers alone.  This  was  not  the  explanation  with  our  rat  alveolar 
macrophages, however, for the entry of T. gondii into these cells did not trigger 
a respiratory burst, as assessed by both intracellular reduction of NBT dye and 
extraceilular release of superoxide.  The failure to  trigger a  respiratory burst 
does not exclude a minor or facilitative role in killing for the small quantities of 
oxygen metabolites produced continuously by the cells (Fig.  2),  but even this 
seems unlikely since pretreatment with PMA (29), a  procedure that exhausted 
the respiratory burst of nearly all the cells (Fig. 3), had no effect on their ability 
to kill Toxoplasma. Thus, although each of the experiments designed to assess 
the importance of oxidative killing has limitations, their combined results leave 
no reasonable doubt that the toxoplasmacidal activity of rat alveolar macrophages 
depends mainly on nonoxidative mechanisms. 
Our results complement those from previous studies of nonoxidative killing of 
other organisms by macrophages. Oxygen-independent microbicidal mechanisms 
have been shown in subcellular macrophage fragments (21, 24) and in oxidatively 1126  OXYGEN-INDEPENDENT  KILLING  BY  ALVEOLAR  MACROPHAGES 
deficient cells (18, 20, 23, 25), including mononuclear phagocytes from patients 
with  chronic  granulomatous  disease  (CGD)  (18,  20),  but  previous  proof of 
nonoxidative antimicrobial mechanisms in intact macrophages has been restricted 
to one report of weak Chlamydiastatic activity in murine peritoneal macrophages 
activated in vitro (22).  Although killing by phagocytes from patients with CGD 
provides very strong evidence for nonoxidative antimicrobial mechanisms, it is 
not absolute proof since these cells commonly can release small levels of oxygen 
metabolites (18, 21). It would also be impractical and unethical to collect large 
numbers of alveolar macrophages from patients with CGD, yet alveolar macro- 
phages are of special interest because pulmonary infection is common, both in 
these and other immunosuppressed patients and in otherwise healthy subjects. It 
is of interest that activated monocyte-derived macrophages from patients with 
CGD  exhibited  toxoplasmastatic  activity  only  (20),  whereas  our  rat  alveolar 
macrophages were toxoplasmacidal; whether this reflects quantitative or quali- 
tative differences in the nonoxidative antimicrobial mechanisms of the two types 
of macrophage remains to be established. 
Because of recent reports that activated, oxidatively deficient macrophage cell 
lines (25) and activated murine peritoneal macrophages under anaerobic condi- 
tions (47) are capable of killing extracellular targets, we attempted to determine 
whether the killing of Toxoplasma by rat alveolar macrophages occurred intra- 
cellularly or extracellularly. Although most of the Toxoplasma were killed within 
1 h  of initial exposure to the macrophage monolayers, the killing probably did 
not occur until after ingestion, for we found no evidence that they were killed 
at  the  cell  surface.  Even  when  Toxoplasma  were  allowed  to  attach  to  the 
macropbages  for  2  h,  their  entry into  the  cells  being  prevented  by  sodium 
fluoride, the organisms remained viable. These results suggest that phagosome 
formation is probably necessary for the killing of Toxoplasma. However, it must 
be stressed that they do not provide absolute proof of this, since sodium fluoride 
can  have  wide-ranging metabolic  effects (42).  Therefore,  it  is  impossible  to 
exclude  a  direct  inhibitory  effect  of  sodium  fluoride  on  a  putative  killing 
mechanism at the cell surface, although Lehrer et al. (41), using Candida albicans, 
found  that  sodium  fluoride  had  no  effect on  the  ability  of rabbit  alveolar 
macrophages to kill yeasts. 
Our studies showing transfer of acridine orange from lysosomes of rat alveolar 
macrophages to intracellular Toxoplasma (Fig. 2) raise the possibility that lyso- 
somal contents could have come into contact with the Toxoplasma (34, 53), but 
they do not prove that phagosome-lysosome fusion is necessary for killing of the 
organism, since previously killed Toxoplasma are incapable of blocking phago- 
some-lysosome fusion (46) and their is evidence from studies with yeast cells that 
dead organisms can even take up acridine orange without phagosome-lysosome 
fusion (34).  Indeed, our  inability to  block  the toxoplasmacidal activity of rat 
alveolar macrophages with weak bases that raise intralysosomal pH (37, 38) is in 
keeping with a  recent observation that the toxoplasmastatic activity of macro- 
phages from CGD patients occurs without phagosome-lysosome fusion (23). On 
the other hand, the results of these experiments with weak bases do not exclude 
an earlier acidification of the phagosome, since weak bases do not raise the pH 
of phagosomes before they fuse with lysosomes (37). This may be pertinent, for CATTERALL  ET  AL.  1127 
Toxoplasma cannot survive at  low pH  (Fig.  3,  and reference 54), and recent 
studies suggest that phagosome acidification occurs before fusion with lysosomes 
during the killing of antibody-coated T. gondii by mouse peritoneal macrophages 
(54). 
The results of our studies do not necessarily imply that oxygen-independent 
antimicrobial mechanisms are more important in alveolar macrophages than in 
macrophages from other anatomical compartments, for recent studies in  our 
laboratory suggest that rat peritoneal macrophages also kill T. gondii by nonoxi- 
dative mechanisms (McCabe, R.  E., and J. S. Remington, manuscript in prepa- 
ration). Nor do they imply that alveolar macrophages kill all microorganisms by 
nonoxidative mechanisms. Toxic metabolites of oxygen almost certainly contrib- 
ute to the killing of Mycobacterium tuberculosis by guinea pig alveolar macrophages 
(55)  and  LegioneUa pneumophila  by  primate  alveolar  macrophages  (56),  for 
example, although  there is  evidence that  nonoxidative mechanisms in  rabbit 
alveolar macrophages may account for the ability of these cells to kill Aspergillus 
spores (57) and possibly Candida albicans (41). 
Rat alveolar macrophages possess both oxidative and nonoxidative antimicro- 
bial mechanisms, and each is effective in the intact cell. Whether an organism 
survives in the cell will depend on its ability to avoid or overcome each of these 
processes. The innate ability of T. gondii  to avoid triggering of the respiratory 
burst  renders  it  particularly  useful  for  studying  nonoxidative  antimicrobial 
mechanisms, and the similarities between rat and human alveolar macrophages 
suggest that this model may be relevant to human pulmonary defenses. Further 
studies are needed to determine the exact nonoxidative event, or series of events, 
responsible for killing T. gondii, but our findings suggest that it is an intracellular 
process and that exposure of the organisms to low intralysosomal pH is unlikely 
to be the crucial step.  Whatever their nature, the nonoxidative killing mecha- 
nisms of rat alveolar macrophages are remarkably effective against T. gondii and 
may play a significant role in the cell's antimicrobial functions. 
Summary 
We  have found that  normal  alveolar  macrophages can  kill  an  intracellular 
parasite by a mechanism that does not involve toxic metabolites of oxygen. We 
studied the interaction between Toxoplasma gondii and rat alveolar macrophages 
in  vitro.  We  were interested in  Toxoplasma  because it  causes pneumonia in 
immunosuppressed patients but not in healthy individuals, and we chose the rat 
because it resembles immunocompetent human subjects in being resistant to T. 
gondii. Resident rat alveolar macrophages could kill large numbers of T. gondii. 
This occurred without a  respiratory burst as judged by intracellular reduction 
of nitroblue tetrazolium and quantitative release of superoxide.  Furthermore, 
scavengers of toxic oxygen metabolites had  no effect on  the toxoplasmacidal 
activity of the alveolar macrophages, nor did prior exhaustion of their respiratory 
burst with PMA.  Whereas acid pH  (e.g., 4.5-6.0) rapidly kills  extracellular T. 
gondii,  raising  of the intralysosomal acid pH  of rat  alveolar macrophages by 
incubating them with weak bases did not inhibit their ability to kill  T. gondii. 
Killing of Toxoplasma occurred within  1 h  of initial exposure to the alveolar 
macrophages. However, there was no evidence that killing preceded ingestion; 1 128  OXYGEN-INDEPENDENT KILLING  BY  ALVEOLAR MACROPHAGES 
Toxoplasma  attached  to  the  surface  of  the  cell  appeared  viable,  and  when 
phagocytosis was blocked with  sodium fluoride the organisms survived.  These 
results indicate  that  rat alveolar macrophages possess a  powerful nonoxidative 
microbicidal mechanism,  which  is  distinct  from acidification of the phagolyso- 
some but which probably involves phagosome formation. This mechanism may 
be clinically relevant,  for we have recently observed that human alveolar mac- 
rophages also kill T. gondii by an oxygen-independent process. 
We thank Dr. R. I. Lehrer for his helpful comments. 
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